Pfizer enters the lucrative weight-loss drug market with a massive $10 billion Metsera acquisition, targeting a $150-200 ...

Pfizer beats Q3 estimates, raises FY guidance, acquires Metsera for obesity drugs, and offers a 7% yield. Read here for an ...

Pfizer on Thursday closed its up to $10 billion acquisition of Metsera after winning shareholder approval, gaining a foothold ...

Some three months after merging, Mallinckrodt and Endo have taken the next step toward their joint future by spinning off ...

Several companies with a focus on obesity and weight management have raised sizable venture funding in the past couple of ...

Private equity firm Permira is in advanced talks with China's HongShan Capital Group (HSG) to sell Italian luxury sneaker ...

The sale comes as private-equity firms are increasing investment in the aerospace and defense sector.

Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera. The pharma giant upped its offer ...

Shopify reports on founders who built businesses without industry experience, highlighting their unique insights and diverse ...

Clessidra Private Equity has taken a majority stake in local Italian baked goods maker Laurieri for an undisclosed sum. The ...

Dubai's AIR, the owner of hookah brand Al Fakher, said on Friday it had agreed to go public in the U.S. through a merger with blank-check firm Cantor Equity Partners III, in a deal valuing the ...